vs
ASCENT INDUSTRIES CO.（ACNT）与太平洋生物科学（ASMB）财务数据对比。点击上方公司名可切换其他公司
ASCENT INDUSTRIES CO.的季度营收约是太平洋生物科学的1.1倍（$11.9M vs $10.8M），ASCENT INDUSTRIES CO.净利率更高（-8.8% vs -85.2%，领先76.5%），太平洋生物科学同比增速更快（57.6% vs 13.3%），ASCENT INDUSTRIES CO.自由现金流更多（$-196.0K vs $-15.2M）
阿森特工业（股票代码ACNT）前身为拆分自探索控股公司的独立上市媒体企业阿森特传媒，后转型为公开上市控股公司，核心子公司为莫尼特罗尼克斯，主营依托子公司开展安防相关业务运营。
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
ACNT vs ASMB — 直观对比
营收规模更大
ACNT
是对方的1.1倍
$10.8M
营收增速更快
ASMB
高出44.3%
13.3%
净利率更高
ACNT
高出76.5%
-85.2%
自由现金流更多
ACNT
多$15.0M
$-15.2M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.9M | $10.8M |
| 净利润 | $-1.0M | $-9.2M |
| 毛利率 | 14.6% | — |
| 营业利润率 | -21.0% | -100.9% |
| 净利率 | -8.8% | -85.2% |
| 营收同比 | 13.3% | 57.6% |
| 净利润同比 | -1.2% | 4.3% |
| 每股收益（稀释后） | $-0.11 | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACNTASMB
| Q4 25 | $11.9M | — | ||
| Q3 25 | $19.7M | $10.8M | ||
| Q2 25 | $18.7M | $9.6M | ||
| Q1 25 | $24.7M | $9.4M | ||
| Q4 24 | $10.5M | $7.4M | ||
| Q3 24 | $20.9M | $6.8M | ||
| Q2 24 | $21.5M | $8.5M | ||
| Q1 24 | $28.0M | $5.8M |
净利润ACNTASMB
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-2.1M | $-9.2M | ||
| Q2 25 | $6.3M | $-10.2M | ||
| Q1 25 | $-2.3M | $-8.8M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $-6.2M | $-9.6M | ||
| Q2 24 | $-926.0K | $-11.2M | ||
| Q1 24 | $-5.5M | $-9.1M |
毛利率ACNTASMB
| Q4 25 | 14.6% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 19.3% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | 8.3% | — |
营业利润率ACNTASMB
| Q4 25 | -21.0% | — | ||
| Q3 25 | -4.1% | -100.9% | ||
| Q2 25 | -14.4% | -115.2% | ||
| Q1 25 | -4.2% | -105.5% | ||
| Q4 24 | -25.4% | — | ||
| Q3 24 | -9.4% | -160.1% | ||
| Q2 24 | -8.6% | -143.0% | ||
| Q1 24 | -15.5% | -185.5% |
净利率ACNTASMB
| Q4 25 | -8.8% | — | ||
| Q3 25 | -10.6% | -85.2% | ||
| Q2 25 | 33.7% | -105.9% | ||
| Q1 25 | -9.3% | -93.6% | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -29.5% | -140.4% | ||
| Q2 24 | -4.3% | -130.7% | ||
| Q1 24 | -19.7% | -156.9% |
每股收益（稀释后）ACNTASMB
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.22 | $-0.72 | ||
| Q2 25 | $0.65 | $-1.33 | ||
| Q1 25 | $-0.23 | $-1.17 | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.61 | $-1.51 | ||
| Q2 24 | $-0.09 | $-1.98 | ||
| Q1 24 | $-0.54 | $-1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.6M | $22.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $87.0M | $182.7M |
| 总资产 | $111.9M | $240.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACNTASMB
| Q4 25 | $57.6M | — | ||
| Q3 25 | $58.0M | $22.5M | ||
| Q2 25 | $60.5M | $24.0M | ||
| Q1 25 | $14.3M | $23.4M | ||
| Q4 24 | $16.1M | $38.3M | ||
| Q3 24 | $8.5M | $28.5M | ||
| Q2 24 | $3.6M | $19.2M | ||
| Q1 24 | $1.3M | $18.7M |
总债务ACNTASMB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACNTASMB
| Q4 25 | $87.0M | — | ||
| Q3 25 | $87.1M | $182.7M | ||
| Q2 25 | $89.7M | $18.1M | ||
| Q1 25 | $91.2M | $27.1M | ||
| Q4 24 | $93.5M | $33.4M | ||
| Q3 24 | $94.7M | $26.0M | ||
| Q2 24 | $101.0M | $34.7M | ||
| Q1 24 | $102.0M | $32.6M |
总资产ACNTASMB
| Q4 25 | $111.9M | — | ||
| Q3 25 | $119.9M | $240.0M | ||
| Q2 25 | $122.6M | $80.8M | ||
| Q1 25 | $152.5M | $99.0M | ||
| Q4 24 | $147.3M | $119.2M | ||
| Q3 24 | $148.6M | $100.3M | ||
| Q2 24 | $158.2M | $115.3M | ||
| Q1 24 | $161.0M | $119.9M |
负债/权益比ACNTASMB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.0K | $-15.1M |
| 自由现金流经营现金流 - 资本支出 | $-196.0K | $-15.2M |
| 自由现金流率自由现金流/营收 | -1.7% | -140.7% |
| 资本支出强度资本支出/营收 | 3.9% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-2.1M | — |
8季度趋势，按日历期对齐
经营现金流ACNTASMB
| Q4 25 | $266.0K | — | ||
| Q3 25 | $1.3M | $-15.1M | ||
| Q2 25 | $-1.4M | $-16.8M | ||
| Q1 25 | $-700.0K | $-23.4M | ||
| Q4 24 | $8.8M | $-51.1M | ||
| Q3 24 | $3.4M | $-15.2M | ||
| Q2 24 | $2.2M | $-17.1M | ||
| Q1 24 | $263.0K | $-18.4M |
自由现金流ACNTASMB
| Q4 25 | $-196.0K | — | ||
| Q3 25 | $695.0K | $-15.2M | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $8.4M | $-51.1M | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $1.9M | $-17.1M | ||
| Q1 24 | $25.0K | $-18.4M |
自由现金流率ACNTASMB
| Q4 25 | -1.7% | — | ||
| Q3 25 | 3.5% | -140.7% | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 80.6% | -695.2% | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 9.1% | -200.6% | ||
| Q1 24 | 0.1% | -317.7% |
资本支出强度ACNTASMB
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.1% | 0.4% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 3.7% | 0.4% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 1.0% | 0.2% | ||
| Q1 24 | 0.9% | 0.2% |
现金转化率ACNTASMB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
ASMB
暂无分部数据
